Knockout of CBLB Greatly Enhances Anti-Tumor Activity of CAR T Cells

被引：2

作者：

Hooper, Kathryn ^{[1
]}

Havens, Kyle ^{[1
]}

Krostag, Anne-Rachel ^{[1
]}

Magee, Michael S. ^{[2
]}

Martin, Unja ^{[1
]}

Gupta, Ankit ^{[2
]}

Smurnyy, Yegor ^{[2
]}

Pechilis, Lisa ^{[2
]}

Rode, Amanda ^{[2
]}

Chavkin, Andrew ^{[2
]}

Grande, Shannon ^{[2
]}

Morgan, Richard A. ^{[2
]}

Jarjour, Jordan ^{[1
]}

Astrakhan, Alexander ^{[1
]}

机构：

[1] Bluebird Bio, Seattle, WA USA

[2] Bluebird Bio, Cambridge, MA USA

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-119247

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

338

引用

页数：2

共 50 条

[31] Harnessing macrophages, while protecting T cells, enhances anti-tumor efficacy
Yamada-Hunter, Sean A.
Theruvath, Johanna
Radosevich, Molly T.
McIntosh, Brianna J.
Freitas, Katherine A.
Martinez-Velez, Naiara
Sotillo, Elena
Leruste, Amaury
Xu, Peng
Desai, Moksha H.
Sahaf, Bita
Banuelos, Allison
Wasserman, Savannah L.
Weissman, Irving L.
Cochran, Jennifer R.
Mackall, Crystal L.
CANCER RESEARCH, 2023, 83 (07)
[32] Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
Sarwish Rafiq
Oladapo O Yeku
Hollie J Jackson
Terence J Purdon
Dayenne G van Leeuwen
Dylan J Drakes
Mei Song
Matthew M Miele
Zhuoning Li
Pei Wang
Su Yan
Jingyi Xiang
Xiaojing Ma
Venkatraman E Seshan
Ronald C Hendrickson
Cheng Liu
Renier J Brentjens
Nature Biotechnology, 2018, 36 : 847 - 856
[33] Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
Rafiq, Sarwish
Yeku, Oladapo O.
Jackson, Hollie J.
Purdon, Terence J.
van Leeuwen, Dayenne G.
Drakes, Dylan J.
Song, Mei
Miele, Matthew M.
Li, Zhuoning
Wang, Pei
Yan, Su
Xiang, Jingyi
Ma, Xiaojing
Seshan, Venkatraman E.
Hendrickson, Ronald C.
Liu, Cheng
Brentjens, Renier J.
NATURE BIOTECHNOLOGY, 2018, 36 (09) : 847 - +
[34] CAR T CELLS UNDERGOING EPIGENETIC REPROGRAMMING BY LOW-DOSE DECITABINE ENHANCES PERSISTENT ANTI-TUMOR EFFICACY IN VIVO
Wang, Yao
Han, Weidong
Tong, Chuan
Wu, Zhiqianag
Dai, Hanren
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A460 - A461
[35] Co-infusion of CAR T cells with aAPCs expressing chemokines and costimulatory ligands enhances the anti-tumor efficacy in mice
Li, Jing
Zhou, Weilin
Li, Dan
Huang, Yong
Yang, Xiao
Jiang, Lin
Hu, Xiaoyi
Yang, Jinrong
Fu, Maorong
Zhang, Mengxi
Wang, Fengling
Li, Jiaqian
Zhang, Yalan
Yang, Yuening
Yan, Feiyang
Gao, Haozhan
Wang, Wei
CANCER LETTERS, 2023, 568
[36] Targeting tumor cells with antibodies enhances anti-tumor immunity
Zhichen Sun
Yang-Xin Fu
Hua Peng
Biophysics Reports, 2018, 4 (05) : 243 - 253
[37] ADAM17 knockout NK or CAR NK cells augment antibody dependent cellular cytotoxicity (ADCC) and anti-tumor activity
Guo, Chao
Fan, Yanying
Aronov, Alexander
Kimura, Nikki
Juat, Damie
Sood, Jessica
Chan, Ivan H.
Trager, James B.
CANCER RESEARCH, 2023, 83 (07)
[38] KNOCKOUT OF THE INHIBITORY RECEPTOR TIGIT ENHANCES ANTI-TUMOR RESPONSE OF EX VIVO EXPANDED NK CELLS
Croom-Perez, Tayler
Hasan, Md Faqrul
Dieffenthaller, Thomas
Robles-Carrillo, Liza
Eloriaga, Jonathan
Copik, Alicja
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A716 - A716
[39] Inosine endows CAR T cells with features of increased stemness and anti-tumor potency
Klysz, Dorota
Freitas, Katie
Malipatlolla, Meena
Maier, Stefanie
Fowler, Carley
Labanieh, Louai
Stuani, Lucille
Daniel, Bence
Sandor, Katalin
Xu, Peng
Huang, Jing
Leruste, Amaury
Keerthi, Vimal
Gkitsas, Nikolaos
Patel, Shabnum
Arredondo-Guerrero, Justin
Fisher, Chris
Asano, Kyle
Patel, Sunny
Satpathy, Ansuman
Davis, Kara
Sotillo, Elena
Feldman, Steven
Mackall, Crystal
CANCER RESEARCH, 2023, 83 (07)
[40] GLUT1 overexpression enhances CAR T cell metabolic fitness and anti-tumor efficacy
Shi, Yuzhe
Kotchetkov, Ivan S.
Dobrin, Anton
Hanina, Sophie A.
Rajasekhar, Vinagolu K.
Healey, John H.
Sadelain, Michel
MOLECULAR THERAPY, 2024, 32 (07) : 2393 - 2405

← 1 2 3 4 5 →